Guggenheim Capital LLC Reduces Position in Teladoc Health, Inc. (NYSE:TDOC)

Guggenheim Capital LLC trimmed its holdings in Teladoc Health, Inc. (NYSE:TDOC) by 32.3% during the fourth quarter, Holdings Channel reports. The institutional investor owned 25,177 shares of the health services provider’s stock after selling 12,031 shares during the period. Guggenheim Capital LLC’s holdings in Teladoc Health were worth $229,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Robeco Institutional Asset Management B.V. boosted its position in shares of Teladoc Health by 21.8% in the fourth quarter. Robeco Institutional Asset Management B.V. now owns 700,166 shares of the health services provider’s stock worth $6,365,000 after acquiring an additional 125,111 shares during the last quarter. Versant Capital Management Inc boosted its position in shares of Teladoc Health by 313.8% in the fourth quarter. Versant Capital Management Inc now owns 3,219 shares of the health services provider’s stock worth $29,000 after acquiring an additional 2,441 shares during the last quarter. Nisa Investment Advisors LLC boosted its position in shares of Teladoc Health by 20,936.8% in the fourth quarter. Nisa Investment Advisors LLC now owns 426,206 shares of the health services provider’s stock worth $3,874,000 after acquiring an additional 424,180 shares during the last quarter. Charles Schwab Investment Management Inc. boosted its position in shares of Teladoc Health by 18.7% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 2,443,713 shares of the health services provider’s stock worth $22,213,000 after acquiring an additional 384,528 shares during the last quarter. Finally, Geode Capital Management LLC boosted its position in shares of Teladoc Health by 0.6% in the fourth quarter. Geode Capital Management LLC now owns 3,947,831 shares of the health services provider’s stock worth $35,894,000 after acquiring an additional 22,664 shares during the last quarter. Hedge funds and other institutional investors own 76.82% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts recently issued reports on the stock. Citigroup decreased their target price on shares of Teladoc Health from $11.00 to $8.75 and set a “neutral” rating on the stock in a research report on Friday. Royal Bank of Canada raised their price target on shares of Teladoc Health from $11.00 to $12.00 and gave the company an “outperform” rating in a report on Friday, January 24th. Bank of America cut their price target on shares of Teladoc Health from $9.50 to $8.00 and set a “neutral” rating on the stock in a report on Friday, April 11th. Oppenheimer cut their price target on shares of Teladoc Health from $14.00 to $12.00 and set an “outperform” rating on the stock in a report on Friday, January 24th. Finally, Piper Sandler cut their price target on shares of Teladoc Health from $13.00 to $12.00 and set an “overweight” rating on the stock in a report on Thursday, February 27th. Twelve equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $10.71.

Insider Activity

In other news, insider Adam C. Vandervoort sold 11,011 shares of the business’s stock in a transaction on Thursday, March 20th. The shares were sold at an average price of $8.42, for a total transaction of $92,712.62. Following the completion of the transaction, the insider now owns 64,308 shares of the company’s stock, valued at approximately $541,473.36. The trade was a 14.62 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Corporate insiders own 0.58% of the company’s stock.

Teladoc Health Stock Down 0.6 %

TDOC stock opened at $7.16 on Tuesday. Teladoc Health, Inc. has a twelve month low of $6.35 and a twelve month high of $15.21. The company has a current ratio of 1.73, a quick ratio of 1.69 and a debt-to-equity ratio of 0.66. The company has a market capitalization of $1.25 billion, a P/E ratio of -1.24 and a beta of 1.73. The firm has a 50 day simple moving average of $8.38 and a 200-day simple moving average of $9.56.

Teladoc Health (NYSE:TDOC) last released its quarterly earnings data on Wednesday, February 26th. The health services provider reported ($0.28) EPS for the quarter, missing analysts’ consensus estimates of ($0.21) by ($0.07). The business had revenue of $640.49 million during the quarter, compared to analyst estimates of $639.44 million. Teladoc Health had a negative return on equity of 10.06% and a negative net margin of 37.91%. On average, equities research analysts predict that Teladoc Health, Inc. will post -1.16 earnings per share for the current fiscal year.

Teladoc Health Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.